APA (7th ed.) Citation

Bauml, J., Grover, N. S., Ronczka, A., Cushing, D., Klichinsky, M., Barton, D., & Dees, E. C. (2021). A phase 1, first in human study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in subjects with HER2 overexpressing solid tumors. Journal of clinical oncology, 39(15_suppl), TPS2660. https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS2660

Chicago Style (17th ed.) Citation

Bauml, Joshua, Natalie Sophia Grover, Amy Ronczka, Daniel Cushing, Michael Klichinsky, Debora Barton, and Elizabeth Claire Dees. "A Phase 1, First in Human Study of Adenovirally Transduced Autologous Macrophages Engineered to Contain an Anti-HER2 Chimeric Antigen Receptor (CAR) in Subjects with HER2 Overexpressing Solid Tumors." Journal of Clinical Oncology 39, no. 15_suppl (2021): TPS2660. https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS2660.

MLA (9th ed.) Citation

Bauml, Joshua, et al. "A Phase 1, First in Human Study of Adenovirally Transduced Autologous Macrophages Engineered to Contain an Anti-HER2 Chimeric Antigen Receptor (CAR) in Subjects with HER2 Overexpressing Solid Tumors." Journal of Clinical Oncology, vol. 39, no. 15_suppl, 2021, p. TPS2660, https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS2660.